Free Shipping* On All Orders
1-800-279-7001 Mon - Sat 9AM to 7PM EST
  • Rated5/5
  • (9 Reviews)
Advantage Multi (Advocate) Buy Now

Advantage Multi for Dogs - Dog Heartworm Control

Advantage Multi for dogs is a broad-spectrum treatment for a wide range of parasites including fleas, heartworms, intestinal worms, ear mites, demodicosis, sarcoptic mange and chewing lice. It is a monthly topical solution that kills around 98-100% fleas within 12 hours. It also reduces Flea Allergy Dermatitis (FAD) and is an ideal treatment for various internal and external parasites.

How does it work?

Manufactured by Bayer, Advantage Multi is a highly potent broad spectrum anthelmintic for destroying fleas, heartworms, roundworm, hookworm, whipworm, tapeworm, ear mites, sarcoptic mange and biting lice. The once-a-month spot on application provides all round protection to all breeds of puppies and dogs.

Imidacloprid and Moxidectin are the active ingredients that attack neurotransmitters of the parasites. This paralyses the pests and kills them eventually. It treats canines for heartworm infections as well.

Reviews
Enid
Cured roundworms effectively

This incredibly good product cured roundworms in my pal. Would recommend this to all dog parents.

craig
Cures sarcoptic mange

This product cured sarcoptic mange in my dog. Highly satisfied.

Ace
Superb

Exceptional product I am going to recommend it to my pals

Lauren Kavanaugh
Works Great

Using Advantage Multi on both of my dogs and cats for years. Both have no fleas or internal parasite problems at all. Love it! It is safe and easy to apply!

<< < 1 2 3 > >> 
Write Reviews

All fields are mandatory

Review Title:
(Maximum 40 words)


Your Review:
Please do not include: HTML, references to other retailers, pricing, personal information, any profane, inflammatory or copyrighted comments, or any copied content.
(Please make sure your review contains at least 100 characters.)


Your Rating:
(Click to rate on scale of 1-5)


Full Name :


E-mail :
Please note that your email address will not published.